Perceptions of RehAtt Mixed Reality System (RehAtt)

June 11, 2026 updated by: University Rehabilitation Institute, Republic of Slovenia

Perceptions of Using RehAtt Mixed Reality System in Stroke Motor Rehabilitation

The study aims to explore the patients' perspective on usability and feasibility of the RehAtt™ mixed-reality system during upper limb, gait and balance function rehabilitation.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Mixed reality is an immersive technology that can integrate virtual objects into the real world and adaptive scenarios. It offers the opportunity to train physical and cognitive aspects in stroke patients. The patients' perspectives were assessed with a semi-structured interview.

Study Type

Interventional

Enrollment (Estimated)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Slovenia
      • Ljubljana, Slovenia, 1000
        • Recruiting
        • University Rehabilitation Institute, Republic of Slovenia
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • first ischaemic or hemorrhagic stroke,
  • one-sided hemiparesis,
  • adequate cognitive abilities.

Exclusion Criteria:

  • severe cognitive impairment,
  • aphasia,
  • known presence of an epileptic seizure in the last year,
  • other orthopaedic and neurological diseases affecting sensory or motor functions,
  • inability to sit independently,
  • severe visual impairment,
  • severe depression.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Device Feasibility
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: RehAtt
Each patient was included in the introduction session (performed by a psychologist), three sessions of occupational therapy and three sessions of physiotherapy. Each session lasted for 30 minutes. Occupational-therapy training was focused on activities aimed at improving upper limb function; physiotherapy training was focused on balance, walking and standing.
Device: RehAtt
Each patient received the RehAtt intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Semi-structured interview
Time Frame: On the day of the end of the intervention
The interview was based on a questionnaire that included rating-scale-based questions on mixed-reality therapy meeting the patient's needs, frustration during the exercise, ease of use, difficulties encountered, motivational aspect, likability and usefulness of each exercise, and open-ended questions on motivation, overall view of the mixed-reality system and possible unwanted effects.
On the day of the end of the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Rehabilitation Institute, Republic of Slovenia

Investigators

  • Principal Investigator: Nataša Bizovičar, MD, PhD, University Rehabilitation Institute, Republic of Slovenia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 11, 2024

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

October 1, 2026

Study Registration Dates

First Submitted

October 11, 2024

First Submitted That Met QC Criteria

October 11, 2024

First Posted (Actual)

October 15, 2024

Study Record Updates

Last Update Posted (Actual)

June 15, 2026

Last Update Submitted That Met QC Criteria

June 11, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • URIS202403

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe